Search

Your search keyword '"Figueiredo-Pontes, Lorena Lobo"' showing total 152 results

Search Constraints

Start Over You searched for: Author "Figueiredo-Pontes, Lorena Lobo" Remove constraint Author: "Figueiredo-Pontes, Lorena Lobo"
152 results on '"Figueiredo-Pontes, Lorena Lobo"'

Search Results

1. Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy

3. Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study

4. STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells

6. NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia

8. TERRA (telomeric repeat-containing RNA) is dysregulated in acute myeloid leukemia

9. Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia

12. Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia.

15. Bioactive Lipids as Chronic Myeloid Leukemia’s Potential Biomarkers for Disease Progression and Response to Tyrosine Kinase Inhibitors

17. Hippo Pathway-related Genes Expression Is Deregulated in Myeloproliferative Neoplasms

18. STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells

19. DNMT1-interacting RNAs block gene-specific DNA methylation

20. Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms

25. Metformin Suppress Cellular and Molecular Processes Related to Maintenance and Proliferation of Myeloproliferative Neoplasm Stem Cell

26. Reduced SLIT2 Are Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in APL Cells

28. Clinical and Functional Studies Reveal That TP73 Isoforms Levels Are Associated with Prognosis and RA-Resistance in Acute Promyelocytic Leukemia

30. Efficacy of the Pan-Bcl-2 Inhibitor (Obatoclax) As a Single Agent to Treat Myeloproliferative Neoplasm in JAK2V617F Murine Transplantation Model

31. Author response for 'Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis'

32. Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis

33. Abnormal Distribution and Function of NK Cells Subsets May Lead to Impaired Tumor Surveillance in a JAK2V617F Myeloproliferative Neoplasm Model

34. NSD1 and NSD2 Transcriptional Levels Might Predict Clinical Outcome in AML Patients

35. C/Ebpg (CCAAT/Enhancer Binding Protein Gamma) Balances Cytotoxic and Secretory Potential of Natural Killer Cells

36. C/EBPγ is dispensable for steady-state and emergency granulopoiesis

37. Abstract A39: Nuclear SET domain (NSD) protein lysine methyltransferases (KMT) are higher expressed in acute myeloid leukemia

38. The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study

40. Feasibility and Relevance of Incorporating Genetic Testing By Next-Generation Sequencing for Acute Myeloid Leukemia Patients Treated in Low- and Middle-Income Countries

41. Microcosting Analysis of Hematopoietic Stem Cell Transplantation and Chemotherapy with Intermediate Doses of Cytarabine in the Treatment of Acute Myeloid Leukemia

42. Real-World Data for FLT3-Mutated Acute Myeloid Leukemia Patients Treated in Resource-Constrained Settings

43. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression

44. Decreased Activity of NK Cells in Myeloproliferative Neoplasms

45. The Use of Cyclosporine in Association with Chemotherapy As Induction Treatment in Patients with Acute Myeloid Leukemia (AML) and High Rhodamine Efflux at Diagnosis Results in Higher Complete Hematological Remission Rates, but Does Not Prolong Overall Survival

48. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression.

Catalog

Books, media, physical & digital resources